Calluna Pharma
Developing first-in-class therapies designed to defeat chronic inflammation and fibrosis at the source.
27 employees · est. 2024 · Oslo, Norway
Yuanyin Bio
Pioneering the future of medicine with groundbreaking RNA technology to tackle unmet clinical needs and develop novel preventive and therapeutic solutions.
est. 2021
Yuanyin Bio is the older company (2024 vs 2021).
Side-by-Side Comparison
| Metric | Calluna Pharma | Yuanyin Bio |
|---|---|---|
| Founded | ||
| Founded | 2024 | 2021 older |
| Headquarters | ||
| Headquarters | Oslo, Norway | Not tracked yet |
| Employees | ||
| Employees | 27 | Not tracked yet |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biopharma, Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series A | Series A |
| Total Funding | ||
| Total Funding | $75.00M | $142.00M |
| Funding Rounds | ||
| Funding Rounds | 1 | 2 |
| Services | ||
| Services | development of first-in-class clinical-stage antibodies, research and development in fibrosis and inflammation, pharmaceutical innovation | Development of new pharmaceutical products, Research and application of circular RNA technology, Creation of therapeutic and preventive medicines |
| Target Customers | ||
| Target Customers | patients with high unmet medical needs related to fibrosis and inflammation, healthcare providers, medical institutions | Healthcare providers, Pharmaceutical companies, Medical research institutions, Biotechnology developers |
| Taxonomy | ||
| Taxonomy | Chronic Inflammation, Fibrosis, Therapies, Clinical Stage, Biotech, Upstream Amplifiers, Immunology, Patient Outcomes, Selective Antibodies, Immunological Diseases, Novel Therapeutics, Unmet Clinical Needs, Disease Spectrum, Therapeutic Pipeline, Biopharmaceutical Innovation | RNA Technology, Circular RNA, Innovative Drugs, Therapeutic Solutions, Preventive Medicine, Unmet Clinical Needs, Drug Development, Therapeutics Pipeline, Novel Therapies, Disease Treatment, Medical Innovation, Biopharmaceuticals, Clinical Research, Disease Targeting |
| Website | ||
| Website | callunapharma.com | therorna.com |
About Calluna Pharma
Calluna Pharma, founded in 2024, is a clinical-stage biotech company based in Norway. The company focuses on developing first-in-class therapies to address chronic inflammation and fibrosis by targeting the upstream amplifiers of diseases. This innovative approach could potentially yield treatments...
About Yuanyin Bio
Yuanyin Bio is emerging as a disruptive force in the Biopharma, Biotechnology, and Pharmaceutical sectors with its focus on circular RNA technology. Founded in 2021, the company aims to revolutionize the medical field through its commitment to creating innovative drugs and therapies. The startup is...
We will tell you when either one moves
BounceWatch watches Calluna Pharma and Yuanyin Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Calluna Pharma and Yuanyin Bio — by email.
Frequently Asked Questions
Compare Calluna Pharma with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Calluna Pharma on 25 Mar 2026, and Yuanyin Bio on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.